Next |
home / stock / acad / acad message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ACAD News Article - Acadia Pharmaceuticals Announces DAYBUE(TM) (trofinetide) is Now A | whytestocks | investorshangout | 04/17/2023 2:40:49 PM |
Is Martin Shkreli in charge of Acadia, or | Doktornolittle | investorshub | 04/09/2023 12:01:33 PM |
30s coming folks, patience | harry crumb | investorshub | 03/13/2023 10:57:16 PM |
$ACAD hopefully Opening will give a boost but | MiamiGent | investorshub | 03/13/2023 1:02:22 PM |
If the price is right, yes | harry crumb | investorshub | 03/13/2023 11:34:59 AM |
Or dumb for not selling when it was | my74nova | investorshub | 03/13/2023 4:13:51 AM |
Phew, $2.1>. Nice! | MiamiGent | investorshub | 03/13/2023 1:37:45 AM |
Mine are at $2.18.....been holding for a looong | my74nova | investorshub | 03/12/2023 12:36:16 AM |
$ACAD...... APPROVED! | MiamiGent | investorshub | 03/11/2023 11:01:42 AM |
Strong ticker | harry crumb | investorshub | 03/01/2023 6:18:27 PM |
Still hold shares at 5.00 here | harry crumb | investorshub | 02/28/2023 3:36:34 PM |
Nice day for acad holders?? | harry crumb | investorshub | 02/28/2023 3:36:07 PM |
$ACAD is covered by 10 analysts: Sell zero Neutral seven | IanFromSI | investorshub | 02/28/2023 2:17:58 PM |
Throughout market turmoil thanks to biden an his | harry crumb | investorshub | 02/23/2023 5:08:44 PM |
1 an 3 month chart are winners for | harry crumb | investorshub | 02/07/2023 6:05:39 PM |
Lmao shorty, the BBs are far more advanced | harry crumb | investorshub | 01/21/2023 8:37:37 PM |
whytestocks: $ACAD News Article - Newly Published Retrospective Analysis Showed Lower All-Cause Mort | whytestocks | investorshangout | 01/03/2023 5:40:46 PM |
An ironic twist of fate. | gi197845 | investorshub | 12/17/2022 1:32:02 AM |
The volume today has been only the selling | gi197845 | investorshub | 12/01/2022 5:40:12 PM |
Pretty standard stuff. Most Pharma companies have legal issues | LasNubes | investorshub | 11/23/2022 5:38:39 PM |
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
-0.74% G/L:
$22.78 Last:
1,335,036 Volume:
$23.07 Open:
$22.95 Close:
ACADIA Pharmaceuticals Inc. Website:
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on June 6, 2025, the Compensation Committee of Acadia’s Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 187,664 shares of common stock and 89,5...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced it will host a R&D day in New York City to discuss its neurological and rare diseases pipeline on Wednesday, June 25, 2025 at 8:30 AM ET. The event will feature members of Acadia’s management team and R&D organization, ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 4:00 p.m. Eastern Time. A live webcast of Acadia’s fireside chat will be accessible on the...